Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
XXII | US
-0.05
-2.92%
Healthcare
Biotechnology
30/06/2024
24/04/2026
1.66
1.75
1.75
1.57
22nd Century Group Inc. an agricultural biotechnology company focuses on tobacco harm reduction reduced nicotine tobacco and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical therapeutic and agricultural uses as well as other applications. 22nd Century Group Inc. was founded in 1998 and is headquartered in Buffalo New York.
View LessLow Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
117.8%1 month
105.9%3 months
103.9%6 months
102.8%-
-
0.38
-10.72
0.43
-0.47
0.39
-
-27.08M
52.18M
52.18M
-
-25.76
-
-1.30
-105.57
0.02
1.04
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.98
Range1M
1.84
Range3M
10.70
Rel. volume
0.83
Price X volume
140.06K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Cumberland Pharmaceuticals Inc | CPIX | Drug Manufacturers-Specialty & Generic | 4.06 | 57.23M | 4.10% | n/a | 81.86% |
| Cannex Capital Holdings Inc | ARRXF | Drug Manufacturers-Specialty & Generic | 0.224 | 57.09M | 6.67% | n/a | 0.50% |
| CDIO | CDIO | Biotechnology | 1.82 | 55.69M | 0.00% | n/a | 28.31% |
| OKYO Pharma Limited | OKYO | Biotechnology | 1.61 | 54.48M | 1.26% | n/a | -107.88% |
| Rani Therapeutics Holdings Inc. Class A Common Stock | RANI | Biotechnology | 0.9389 | 54.33M | 2.56% | n/a | 1243.32% |
| LYRA THERAPEUTICS INC | LYRA | Biotechnology | 0.8 | 52.37M | 10.34% | n/a | 118.63% |
| Cognition Therapeutics Inc. Common Stock | CGTX | Biotechnology | 1.28 | 51.37M | 1.59% | n/a | 2.71% |
| Gain Therapeutics Inc. Common Stock | GANX | Biotechnology | 1.97 | 50.30M | 4.23% | n/a | 6.85% |
| PEPG | PEPG | Biotechnology | 1.54 | 50.19M | -3.14% | n/a | 12.52% |
| Tenax Therapeutics Inc | TENX | Biotechnology | 14.3 | 48.75M | 2.36% | n/a | 3.14% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 21.77 | 33.16M | -2.81% | n/a | 204.46% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.57 | 11.01M | -3.37% | n/a | 58.43% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5165 | 7.55M | -0.67% | 0.03 | 16.03% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.38 | 3.52M | 0.23% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.199 | 1.89M | 1.38% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.27 | 699.77K | -6.62% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0055 | 507.18K | -37.50% | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.47 | 0.53 | Cheaper |
| Ent. to Revenue | 0.39 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.38 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 103.88 | 72.80 | Riskier |
| Debt to Equity | -10.72 | -1.23 | Cheaper |
| Debt to Assets | 0.43 | 0.25 | Expensive |
| Market Cap | 52.18M | 3.66B | Emerging |